DOUGLAS KLASSETT: Open Payments
NPI 1174557516 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,616 in 138 payments from 30 companies in 2025. Trend: 2023 $1,955 · 2024 $2,930 · 2025 $2,616
Food & beverage: $2,616
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 21 | $381 |
| Novo Nordisk Inc | 16 | $330 |
| AstraZeneca Pharmaceuticals LP | 9 | $301 |
| ABBVIE INC. | 19 | $249 |
| Teva Pharmaceuticals USA, Inc. | 8 | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $132 |
| Phathom Pharmaceuticals, Inc. | 2 | $130 |
| Lilly USA, LLC | 7 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $115 |
| Abbott Laboratories | 5 | $100 |
Products named: Ozempic, PREVNAR 20, FARXIGA, AJOVY, VOQUEZNA, NURTEC ODT, XIFAXAN, JARDIANCE.
Industry payments across VA — which companies pay providers there.
